Reorganization, Money Will Cure Cancer In 21st Century, NCLAC Report Promises.
Three Geneticists Of “Knockout” Mice Fame Win Lasker Award For Basic Research.
Caryn Lerman Recruited By Univ. Of Pennsylvania.
BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.
FDA Approves Xeloda For Breast Cancer After Failure Of Anthracycline Treatment.
Impath Buys Clinical Studies Support Services Network.
MGI Pharma, MethylGene Begin Phase II Trial Of MG98.
Vasopermeation Technology Awarded Patent For CA Firm.
FDA Approves Xeloda For Breast Cancer Treatment.
Trending Stories
- ACOG says it will no longer accept federal funding
- Gardiner Harris, acclaimed health care and pharma journalist, on his New York Times bestselling book
- Knight Cancer Institute receives record-setting $2B gift from the Knights—and self-governance within OHSU
Brian Druker returns to executive role as president of the new Knight Cancer Group - Robert A. Winn on his new vision to train cancer center leaders: “I had a big bold idea and an ‘Aha!’ moment.”
- Pediatric cancer research cut from spending legislation at last minute
Republicans quietly removed hard-won pediatric cancer bills - “If I’m not dying, I better go live.” Christy Erickson’s cancer diagnosis led to life as a motorcyclist and strongman competitor